Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
1.
Br J Dermatol ; 181(4): 796-804, 2019 10.
Article in English | MEDLINE | ID: mdl-30737999

ABSTRACT

BACKGROUND: Alterations of the skin microbiome have been associated with atopic dermatitis (AD) and its severity. The nasal microbiome in relation to AD severity is less well studied. OBJECTIVES: We aimed to characterize the nasal and skin microbiomes in children with AD in relation to disease severity. In addition, we explored the differences and correlations between the nasal and skin communities. METHODS: We characterized the microbial composition of 90 nasal and 108 lesional skin samples cross-sectionally from patients with AD, using 16S-rRNA sequencing. In addition, a quantitative polymerase chain reaction was performed for Staphylococcus aureus and Staphylococcus epidermidis on the skin samples, and AD severity was estimated using the self-administered Eczema Area and Severity Index. RESULTS: We found an association between the microbial composition and AD severity in both the nose and skin samples (R2  = 2·6%; P = 0·017 and R2  = 7·0%; P = 0·004), strongly driven by staphylococci. However, other species also contributed, such as Moraxella in the nose. Skin lesions were positive for S. aureus in 50% of the children, and the presence and the load of S. aureus were not associated with AD severity. Although the nose and skin harbour distinct microbial communities (n = 48 paired samples; P < 0·001), we found that correlations exist between species in the nose and (other) species on the skin. CONCLUSIONS: Our results indicate that both the nasal and the skin microbiomes are associated with AD severity in children and that, next to staphylococci, other species contribute to this association.


Subject(s)
Dermatitis, Atopic/diagnosis , Microbiota/immunology , Nasal Mucosa/microbiology , Severity of Illness Index , Skin/microbiology , Adolescent , Child , Child, Preschool , Cross-Sectional Studies , DNA, Bacterial/isolation & purification , Dermatitis, Atopic/immunology , Dermatitis, Atopic/microbiology , Female , Humans , Infant , Infant, Newborn , Male , Microbiota/genetics , Nasal Mucosa/immunology , RNA, Ribosomal, 16S/genetics , Skin/immunology , Staphylococcus aureus/genetics , Staphylococcus aureus/immunology , Staphylococcus aureus/isolation & purification , Staphylococcus epidermidis/genetics , Staphylococcus epidermidis/immunology , Staphylococcus epidermidis/isolation & purification
2.
Drug Metab Dispos ; 46(11): 1596-1607, 2018 11.
Article in English | MEDLINE | ID: mdl-30158249

ABSTRACT

Colon microbiota-based drug metabolism has received little attention thus far in the process of drug development, whereas the role of gut microbiota in clinical safety and efficacy of drugs has become more clear. Many of these studies have been performed using animal studies, but the translational value of these data with respect to drug pharmacokinetics, efficacy, and safety is largely unknown. To investigate human colon microbiota-mediated drug metabolism, we applied a recently developed ex vivo fermentation screening platform, in which human colonic microbiota conditions are simulated. A set of 12 drugs (omeprazole, simvastatin, metronidazole, risperidone, sulfinpyrazone, sulindac, levodopa, dapsone, nizatidine, sulfasalazine, zonisamide, and acetaminophen) was incubated with human colon microbiota under strictly anaerobic conditions, and samples were analyzed using high-performance liquid chromatograph-UV-high-resolution mass spectrometry analysis. The human microbiota in the fermentation assay consisted of bacterial genera regularly encountered in human colon and fecal samples and could be reproducibly cultured in independent experiments over time. In addition, fully anaerobic culture conditions could be maintained for 24 hours of incubation. Five out of the 12 included drugs (sulfasalazine, sulfinpyrazone, sulindac, nizatidine, and risperidone) showed microbiota-based biotransformation after 24 hours of incubation in the ex vivo fermentation assay. We demonstrated that drug metabolites formed by microbial metabolism can be detected in a qualitative manner and that the data are in accordance with those reported earlier for in vivo metabolism. In conclusion, we present a research tool to investigate human colon microbiota-based drug metabolism that may be applied to enable translatability of microbiota-based drug metabolism.


Subject(s)
Fermentation/physiology , Gastrointestinal Microbiome/physiology , Inactivation, Metabolic/physiology , Pharmaceutical Preparations/metabolism , Adult , Colon/metabolism , Colon/microbiology , Feces/microbiology , Female , Humans , Male , Middle Aged
3.
Neurogastroenterol Motil ; 30(6): e13299, 2018 06.
Article in English | MEDLINE | ID: mdl-29383802

ABSTRACT

BACKGROUND: Irritable bowel syndrome (IBS) is a common gastrointestinal disorder associated with altered gastrointestinal microflora and increased nociception to colonic distension. This visceral hypersensitivity can be reversed in our rat maternal separation model by fungicides. Menthacarin® is a proprietary combination of essential oils from Mentha x piperita L. and Carum carvi. Because these oils exhibit antifungal and antibacterial properties, we investigated whether Menthacarin® can reverse existing visceral hypersensitivity in maternally separated rats. METHODS: In non-handled and maternally separated rats, we used the visceromotor responses to colorectal distension as measure for visceral sensitivity. We evaluated this response before and 24 hours after water-avoidance stress and after 7 days treatment with Menthacarin® or control. The pre- and post-treatment mycobiome and microbiome were characterized by sequencing of fungal internal transcribed spacer 1 (ITS-1) and bacterial 16s rDNA regions. In vitro antifungal and antimicrobial properties of Menthacarin® were studied with radial diffusion assay. KEY RESULTS: Menthacarin® inhibited in vitro growth of yeast and bacteria. Water-avoidance caused visceral hypersensitivity in maternally separated rats, and this was reversed by treatment. Multivariate analyses of ITS-1 and 16S high throughput data showed that maternal separation, induced changes in the myco- and microbiome. Menthacarin® treatment of non-handled and maternally separated rats shifted the mycobiomes to more similar compositions. CONCLUSIONS & INFERENCES: The development of visceral hypersensitivity in maternally separated rats and the Menthacarin® -mediated reversal of hypersensitivity is associated with changes in the mycobiome. Therefore, Menthacarin® may be a safe and effective treatment option that should be tested for IBS.


Subject(s)
Hyperalgesia/drug therapy , Mycobiome/drug effects , Oils, Volatile/administration & dosage , Plant Oils/administration & dosage , Visceral Pain/drug therapy , Animals , Animals, Newborn , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/isolation & purification , Antifungal Agents/administration & dosage , Antifungal Agents/isolation & purification , Drug Combinations , Hyperalgesia/microbiology , Hyperalgesia/psychology , Male , Maternal Deprivation , Mentha piperita , Mycobiome/physiology , Oils, Volatile/isolation & purification , Plant Oils/isolation & purification , Rats , Rats, Long-Evans , Visceral Pain/microbiology , Visceral Pain/psychology
4.
Br J Nutr ; 112(4): 536-46, 2014 Aug 28.
Article in English | MEDLINE | ID: mdl-24925303

ABSTRACT

In the present double-blind, randomised, parallel intervention study, the effects of the intake of galacto-oligosaccharides (GOS) on the gut microbiota of twelve healthy adult subjects (aged 18-45 years with a normal BMI (18-25 kg/m²)) receiving amoxicillin (AMX) treatment were determined. All the subjects were treated with AMX (375 mg; three times per d) for 5 d and given either GOS (n 6) or placebo (maltodextrin, n 6) (2·5 g; three times per d) during and 7 d after AMX treatment. Faecal samples were collected twice before starting the treatment and on days 2, 5, 8, 12, 19 and 26. Due to AMX treatment, a decrease in the abundance of Bifidobacterium spp., an overgrowth of Enterobacteriaceae, and a disruption of the metabolic activity of the microbiota (increase in succinate, monosaccharide and oligosaccharide levels in the faecal samples) were observed in both groups (P< 0·05). Positive effects of GOS intake were observed on the levels of bifidobacteria, although not found to be significant. Data revealed that the levels of bifidobacteria were higher upon GOS intake than upon placebo intake, especially after AMX treatment. The activity of bifidobacteria and subsequent cross-feeding activity of the microbiota upon GOS intake compared with those upon placebo intake were reflected by the significant increase in butyrate levels (P< 0·05) in the faecal samples after AMX treatment. Despite the small number of subjects, our findings confirm previous results obtained in vitro, namely that GOS intake supports the recovery of the beneficial bifidobacteria and, indirectly, the production of butyrate after AMX treatment.


Subject(s)
Anti-Bacterial Agents/adverse effects , Bifidobacterium/drug effects , Diarrhea/prevention & control , Enterobacteriaceae/drug effects , Intestinal Mucosa/drug effects , Oligosaccharides/therapeutic use , Prebiotics , Adolescent , Adult , Amoxicillin/adverse effects , Bifidobacterium/growth & development , Bifidobacterium/isolation & purification , Bifidobacterium/metabolism , Butyric Acid/analysis , Butyric Acid/metabolism , Diarrhea/chemically induced , Double-Blind Method , Enterobacteriaceae/growth & development , Enterobacteriaceae/isolation & purification , Enterobacteriaceae/metabolism , Feces/chemistry , Feces/microbiology , Female , Follow-Up Studies , Humans , Intestinal Mucosa/microbiology , Lower Gastrointestinal Tract/drug effects , Lower Gastrointestinal Tract/microbiology , Male , Microbial Viability/drug effects , Monosaccharides/analysis , Monosaccharides/metabolism , Oligosaccharides/adverse effects , Oligosaccharides/analysis , Oligosaccharides/metabolism , Prebiotics/adverse effects , Prebiotics/analysis , Young Adult
5.
Poult Sci ; 92(10): 2713-23, 2013 Oct.
Article in English | MEDLINE | ID: mdl-24046419

ABSTRACT

Microbiota plays a role in the release and absorption of nutrients from feed components, thereby affecting digesta composition and moisture content of the excreta. The objective of the current study was to determine the effects of 5 different diets varying in ingredients (medium-chain fatty acids, nonstarch polysaccharides, and starch) on the microbiota composition of ileal digesta of broiler chickens and excreta DM content. Each treatment was repeated 6 times in cages each containing 18 Ross 308 broilers, with growth performance measured from 0 to 34 d of age and excreta DM and ileal microbiota composition analyzed at 34 d of age. Microbiota composition was evaluated using a novel ribosomal RNA microarray technology containing 370 different probes covering various genera, groups of microbial species, and individual species of the chicken gut microbiota, of which 321 had a signal above the background threshold. Replacing part of the animal fat and soybean oil in the wheat-based diet with medium-chain fatty acids (MCFA; 0.3% C10 and 2.7% C12) improved feed efficiency compared with the other dietary treatments. This coincided with a suppression of gram-positive bacteria belonging to the phylum of the Firmicutes, including Lactobacillus species, and species belonging to the family of the Enterococcaceae and Micrococcaceae, whereas the gram-negative bacteria belonging to the family of the Enterobacteriaceae were promoted. None of the other diets used in the present study notably changed the ileal digesta bacteria composition. Excreta DM content was not affected by dietary treatment. The variation between individual birds per dietary treatment was more pronounced than variation caused by feed composition, with the exception of the digesta microbiota of the birds fed the MCFA diet. It is concluded that a diet with MCFA significantly changes the ileal microbiota composition, whereas the effect of the other diets on the composition of the microbiota and excreta DM content is small in broiler chickens.


Subject(s)
Animal Feed/analysis , Chickens/microbiology , Chickens/physiology , Gastrointestinal Contents/microbiology , Ileum/microbiology , Microbiota , Animal Nutritional Physiological Phenomena , Animals , Bacteria/classification , Bacteria/genetics , Bacteria/metabolism , Chickens/growth & development , Diet/veterinary , Fatty Acids/metabolism , Feces/chemistry , Male , Microarray Analysis/veterinary , Oligonucleotide Array Sequence Analysis/veterinary , Polymerase Chain Reaction/veterinary , Polysaccharides/metabolism , RNA Probes/genetics , RNA Probes/metabolism , Starch/metabolism
6.
J Microbiol Methods ; 92(3): 387-97, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23266580

ABSTRACT

Antibiotic treatments can lead to a disruption of the human microbiota. In this in-vitro study, the impact of antibiotics on adult intestinal microbiota was monitored in a new high-throughput approach: a fermentation screening-platform was coupled with a phylogenetic microarray analysis (Intestinal-chip). Fecal inoculum from healthy adults was exposed in a fermentation screening-platform to seven widely-used antibiotics during 24h in-vitro fermentation and the microbiota composition was subsequently determined with the Intestinal-chip. Phylogenetic microarray analysis was first verified to be reliable with respect to variations in the total number of bacteria and presence of dead (or inactive) cells. Intestinal-chip analysis was then used to identify and compare shifts in the intestinal microbial composition after exposure to low and high dose (1µgml(-1) and 10µgml(-1)) antibiotics. Observed shifts on family, genus and species level were both antibiotic and dose dependent. Stronger changes in microbiota composition were observed with higher doses. Shifts mainly concerned the bacterial groups Bacteroides, Bifidobacterium, Clostridium, Enterobacteriaceae, and Lactobacillus. Within bacterial groups, specific antibiotics were shown to differentially impact related species. The combination of the in-vitro fermentation screening platform with the phylogenetic microarray read-outs has shown to be reliable to simultaneously analyze the effects of several antibiotics on intestinal microbiota.


Subject(s)
Anti-Bacterial Agents/pharmacology , Biota , Feces/microbiology , Metagenome/drug effects , Adult , Bacteriological Techniques/methods , Female , High-Throughput Screening Assays/methods , Humans , Male , Microarray Analysis/methods , Middle Aged , Models, Theoretical , Phylogeny
7.
Benef Microbes ; 2(2): 115-28, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21831793

ABSTRACT

To provide insight in the molecular basis for intestinal host-microbe interactions, we determined the genome-wide transcriptional response of human intestinal epithelial cells following exposure to cells of Bifidobacterium breve. To select an appropriate test system reflecting inflammatory conditions, the responsiveness to TNF-α was compared in T84, Caco-2 and HT-29 cells. The highest TNF-α response was observed in HT-29 cells and this cell line was selected for exposure to the B. breve strains M-16V, NR246 and UCC2003. After one hour of bacterial pre-incubation followed by two hours of additional TNF-α stimulation, B. breve M-16V (86%), but to a much lesser extent strains NR246 (50%) or UCC2003 (32%), showed a strain-specific reduction of the HT-29 transcriptional response to the inflammatory treatment. The most important functional groups of genes that were transcriptionally suppressed by the presence of B. breve M-16V, were found to be involved in immune regulation and apoptotic processes. About 54% of the TNF-α induced genes were solely suppressed by the presence of B. breve M-16V. These included apoptosis-related cysteine protease caspase 7 (CASP7), interferon regulatory factor 3 (IRF3), amyloid beta (A4) precursor proteinbinding family A member 1 (APBA1), NADPH oxidase (NOX5), and leukemia inhibitory factor receptor (LIFR). The extracellular IL-8 concentration was determined by an immunological assay but did not change significantly, indicating that B. breve M-16V only partially modulates the TNF-α pathway. In conclusion, this study shows that B. breve strains modulate gene expression in HT-29 cells under inflammatory conditions in a strain-specific way.


Subject(s)
Bifidobacterium/physiology , Gene Expression/genetics , HT29 Cells/microbiology , Tumor Necrosis Factor-alpha/pharmacology , Apoptosis/genetics , Cell Line , Down-Regulation/genetics , Epithelial Cells/physiology , Gene Expression/drug effects , HT29 Cells/immunology , HT29 Cells/pathology , Humans , Inflammation , Oligonucleotide Array Sequence Analysis , Pilot Projects , Probiotics , RNA, Bacterial/genetics , Species Specificity , Time Factors , Transcriptome
8.
J Dent Res ; 87(11): 1016-20, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18946007

ABSTRACT

A good definition of commensal microflora and an understanding of its relation to health are essential in preventing and combating disease. We hypothesized that the species richness of human oral microflora is underestimated. Saliva and supragingival plaque were sampled from 71 and 98 healthy adults, respectively. Amplicons from the V6 hypervariable region of the small-subunit ribosomal RNA gene were generated by PCR, pooled into saliva and plaque pools, and sequenced by means of the Genome Sequencer 20 system at 454 Life Sciences. Data were evaluated by taxonomic and rarefaction analyses. The 197,600 sequences generated yielded about 29,000 unique sequences, representing 22 taxonomic phyla. Grouping the sequences in operational taxonomic units (6%) yielded 3621 and 6888 species-level phylotypes in saliva and plaque, respectively. This work gives a radically new insight into the diversity of human oral microflora, which, with an estimated number of 19,000 phylotypes, is considerably higher than previously reported.


Subject(s)
Dental Plaque/microbiology , Saliva/microbiology , Adult , Bacterial Typing Techniques , DNA, Bacterial/analysis , Humans , RNA, Bacterial/genetics , RNA, Ribosomal, 16S/genetics , Sequence Analysis, DNA
9.
Int J Food Microbiol ; 112(3): 195-9, 2006 Dec 01.
Article in English | MEDLINE | ID: mdl-16777253

ABSTRACT

In the food processing industry, unwanted occurrence and growth of spoilage and pathogenic microorganisms is a key concern. A prime example is the extremely heat resistant bacterial endospores, microbial survival structures, that create problems due to their ability to survive classical thermal treatments and their ability to subsequently germinate and form actively growing vegetative cells. Research on food spoilage Bacillus subtilis isolates using the Amplified Fragment Length Polymorphism (AFLP) technology and micro-array technology has identified a number of genomic factors correlated to the level of spore heat resistance. Strains could be classified according to these genomic markers. In addition, it was shown with the sequenced B. subtilis laboratory strain that sporulation in the presence of in particular calcium ions in a cocktail of calcium, magnesium, iron, manganese and potassium promotes thermal resistance of developing spores. This physiological observation correlated with an increased expression during sporulation of genes encoding small acid soluble spore proteins. Screening of ingredients using DNA-chip based techniques identifying the above indicated molecular markers, should allow in the future the identification of the occurrence of spoilage and pathogenic bacteria and prediction of their thermal preservation stress resistance. Currently various projects aiming at the integration of genomics data and micro(nano)-technology, a prerequisite if the alluded to ingredient Quality Control is going to succeed, are running or are being set-up. Information from these projects will be used together with the requirements of product organoleptic quality to derive robust integrated food safety and food quality processing parameters. Such parameters should form the basis of future food Quality Assurance systems.


Subject(s)
Bacillus subtilis/isolation & purification , Consumer Product Safety , Food Contamination/analysis , Food Microbiology , Microarray Analysis/methods , Bacillus subtilis/growth & development , Bacillus subtilis/physiology , Colony Count, Microbial , Genetic Markers , Hot Temperature , Humans , Polymorphism, Restriction Fragment Length , Spores, Bacterial/physiology
10.
Curr Genet ; 33(2): 151-6, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9506904

ABSTRACT

GPD regulatory sequences were used to express a phleomycin resistance gene (Sh ble) in Schizophyllum commune, resulting in high numbers of phleomycin-resistant transformants. Attempts to express heterologous genes coding for hygromycin B phosphotransferase (hph), aminoglycoside phosphotransferase (apt), beta-glucuronidase (uidA) and beta-galactosidase (lacZ) using the same regulatory sequences were not successful and no mRNA could be detected. Cloning the hph and uidA genes in an internally deleted GPD gene resulted in truncated transcripts which ended within the 5'-parts of the heterologous genes. Cloning of the same genes as transcriptional fusions downstream from the Sh ble gene also resulted in truncated transcripts ending in the 5'-parts of these heterologous genes. It is suggested that AT-rich sequences in heterologous genes might be involved in generating these truncated transcripts, thereby preventing expression in S. commune.


Subject(s)
Gene Expression Regulation, Enzymologic , Gene Expression Regulation, Fungal , Schizophyllum/genetics , Base Sequence , DNA, Fungal/chemistry , Glucuronidase/genetics , Glyceraldehyde-3-Phosphate Dehydrogenases/genetics , Kanamycin Kinase/genetics , Molecular Sequence Data , Phosphotransferases (Alcohol Group Acceptor)/genetics , Schizophyllum/enzymology , beta-Galactosidase/genetics
11.
EMBO J ; 13(24): 5848-54, 1994 Dec 15.
Article in English | MEDLINE | ID: mdl-7813424

ABSTRACT

The SC3p hydrophobin of Schizophyllum commune is a small hydrophobic protein (100-101 amino acids with eight cysteine residues) that self-assembles at a water/air interface and coats aerial hyphae with an SDS-insoluble protein membrane, at the outer side highly hydrophobic and with a typical rodlet pattern. SC3p monomers in water also self-assemble at the interfaces between water and oils or hydrophobic solids. These materials are then coated with a 10 nm thick SDS-insoluble assemblage of SC3p making their surfaces hydrophilic. Hyphae of S. commune growing on a Teflon surface became firmly attached and SC3p was shown to be present between the fungal cell wall and the Teflon. Decreased attachment of hyphae to Teflon was observed in strains not expressing SC3, i.e. a strain containing a targeted mutation in this gene and a regulatory mutant thn. These findings indicate that hydrophobins, in addition to forming hydrophobic wall coatings, play a role in adherence of fungal hyphae to hydrophobic surfaces.


Subject(s)
Cell Adhesion/physiology , Cell Wall/chemistry , Fungal Proteins/chemistry , Schizophyllum/chemistry , Adsorption , Cell Wall/physiology , Chemical Phenomena , Chemistry, Physical , Fungal Proteins/isolation & purification , Genes, Fungal , Membranes/chemistry , Oils , Polytetrafluoroethylene , Protein Conformation , Schizophyllum/genetics , Schizophyllum/physiology , Water
12.
Curr Genet ; 26(2): 179-83, 1994 Aug.
Article in English | MEDLINE | ID: mdl-8001174

ABSTRACT

Regulatory sequences of the glyceraldehyde-3-phosphate-dehydrogenase (GPD) gene from the homobasidiomycete Schizophyllum commune were fused to the coding sequence of the ble gene from Streptoalloteichus hindustanus, which codes for a phleomycin-binding protein. The resulting construct transformed S. commune to phleomycin resistance at a high frequency (up to 10(4) transformants/microgram DNA per 10(7) protoplasts) when regeneration was done in 0.5 M MgSO4. A similar construct with regulatory sequences from Aspergillus nidulans failed to give transformants, showing the importance of homologous regulatory sequences for the expression of genes in S. commune. The homologous GPD promoter could be deleted up to position -130 without any effect on the number of phleomycin-resistant transformants. This is the first effective stable transformation system in a homobasidiomycete employing antibiotic resistance.


Subject(s)
Drug Resistance, Microbial/genetics , Glyceraldehyde-3-Phosphate Dehydrogenases/genetics , Schizophyllum/genetics , Transformation, Genetic , Actinomycetales/genetics , Gene Expression , Glyceraldehyde-3-Phosphate Dehydrogenases/biosynthesis , Phleomycins/pharmacology , Plasmids , Promoter Regions, Genetic , Protoplasts/physiology , Recombinant Fusion Proteins/biosynthesis , Regulatory Sequences, Nucleic Acid , Schizophyllum/drug effects , Transcription, Genetic
13.
J Gen Microbiol ; 139(9): 2083-90, 1993 Sep.
Article in English | MEDLINE | ID: mdl-8245835

ABSTRACT

The Sc7 and Sc14 genes are specifically expressed in the dikaryon of the basidiomycete fungus Schizophyllum commune during fruiting. These genes are closely linked (within 6 kb) and highly similar in gene structure and nucleotide sequence (70% identical nucleotides in their coding regions). The encoded proteins (204 and 214 amino acids, respectively) have 87% similarity in amino acids (56% of the amino acids are identical). They contain putative signal sequences for secretion, are rich in aromatic amino acids which are generally located at similar positions, and they are generally hydrophilic. Inspection of databanks showed similarities with pathogenesis-related proteins (PR1) from plants, testis-specific proteins from mammals and venom allergen proteins from insects. An antibody raised against a Sc7 fusion protein showed the presence of the Sc7 protein in the culture medium and in the fruit bodies where it is apparently loosely associated with hyphal walls.


Subject(s)
Fungal Proteins/genetics , Genes, Fungal , Schizophyllum/genetics , Amino Acid Sequence , Base Sequence , Extracellular Space/metabolism , Fungal Proteins/metabolism , Molecular Sequence Data , Multigene Family , Schizophyllum/growth & development , Schizophyllum/metabolism , Sequence Homology, Amino Acid
14.
Mol Gen Genet ; 238(1-2): 91-6, 1993 Apr.
Article in English | MEDLINE | ID: mdl-8479444

ABSTRACT

Problems encountered in our attempts to achieve expression of heterologous genes, driven by ascomycetous regulatory sequences, in homobasidiomycetes led us to develop a gene-reporter system based on the expression of homologous genes in Schizophyllum commune. Internal deletions were made in the coding sequences of the regulated Sc4 gene and the constitutively expressed GPD gene. After introduction of these constructs into S. commune it was found that the expected truncated transcripts were produced. The internally deleted Sc4 gene, containing 1140bp of upstream and 200 bp of downstream sequences, was only expressed in dikaryons at the time of fruiting (as was the resident Sc4 gene) but not at all in monokaryons, indicating that the construct contained all regulatory sequences necessary and sufficient to confer control by the mating-type genes and expression during fruiting. The internally deleted GPD gene, containing 1300 bp of upstream and 150 bp of downstream sequences, was expressed both in monokaryons and dikaryons at levels similar to those of the resident GPD gene, indicating that all sequences necessary for proper expression were present. This reporter-gene system may be applicable to the analysis of cis-regulatory sequences of these genes. Furthermore, heterologous genes may be inserted into the well-expressed GPD deletion construct to obtain expression of such genes in S. commune and possibly in other homobasidiomycetes.


Subject(s)
Gene Deletion , Genes, Fungal , Genes, Mating Type, Fungal , Schizophyllum/genetics , Blotting, Northern , Blotting, Southern , DNA, Fungal/genetics , DNA, Fungal/isolation & purification , Gene Expression , Genes, Regulator , RNA, Fungal/genetics , RNA, Fungal/isolation & purification , Regulatory Sequences, Nucleic Acid , Restriction Mapping , Transformation, Genetic
15.
Curr Genet ; 22(6): 447-54, 1992 Dec.
Article in English | MEDLINE | ID: mdl-1473176

ABSTRACT

GPD genes encoding glyceraldehyde-3-phosphate dehydrogenase were isolated from the homobasidiomycetes Schizophyllum commune, Phanerochaete chrysosporium and Agaricus bisporus. All three species contain one transcriptionally active GPD gene, but A. bisporus also contains an inactive GPD gene (tandemly linked to the active gene). These genes contain 5-9 introns located at conserved positions, differing (except in one case) from intron positions in ascomycetous GPD genes. The predicted amino-acid sequences of the proteins encoded by the three active GPD genes are highly homologous. A comparison with protein sequences from filamentous ascomycetes shows a clear distinction, whereas the GPD genes from ascomycetous yeasts are quite distinct from both the filamentous ascomycetes and basidiomycetes. Promoter regions of ascomycetous GPD genes do not correspond to those of the GPD genes of basidiomycetes which may (partly) explain poor expression in basidiomycetes of introduced genes driven by an ascomycete GPD promoter.


Subject(s)
Basidiomycota/genetics , Glyceraldehyde-3-Phosphate Dehydrogenases/genetics , Amino Acid Sequence , Base Sequence , Basidiomycota/enzymology , DNA, Fungal , Genes, Fungal , Molecular Sequence Data , Phylogeny , Restriction Mapping , Sequence Homology, Amino Acid
16.
Exp Eye Res ; 54(5): 803-6, 1992 May.
Article in English | MEDLINE | ID: mdl-1623966

ABSTRACT

Comparison of the partial sequences of the human beta B2-1- and beta B2-2-crystallin genes with orthologous rat or calf sequences shows that the fourth exon sequence of the human beta B2-2 gene contains a one triplet deletion and a mutated splice acceptor site. No transcripts from the beta B2-2-crystallin gene could be detected in the human lens. These data suggest that the human beta B2-2-crystallin gene is a pseudogene.


Subject(s)
Crystallins/genetics , Pseudogenes/physiology , Base Sequence , Blotting, Northern , Exons/physiology , Humans , Molecular Sequence Data , Mutation , Oligonucleotide Probes
17.
Gene ; 90(2): 199-205, 1990 Jun 15.
Article in English | MEDLINE | ID: mdl-2401401

ABSTRACT

The nucleotide (nt) sequences of the Sc3 and Sc4 genes of the filamentous fungus Schizophyllum commune, and the deduced amino acid (aa) sequences, were determined; moreover, the previously published sequence for the Sc1 gene [Dons et al., EMBO J. 3 (1984) 2101-2106] was corrected. All three independently isolated genes were found to have similar structures and nt sequences of their coding regions. At the aa level the homology is 43-62% (63-69% in the C-terminal parts of the proteins), the hydrophobic aa predominate and the hydrophobicity patterns are similar. All three proteins contain leader sequences and eight cysteines among about 110 aa, conserved at the same positions. Yet these genes are differentially regulated: Sc1 and Sc4 are only expressed at high levels in fruiting dikaryons, whereas Sc3 is highly expressed in both monokaryons and dikaryons, independent from fruiting.


Subject(s)
Base Sequence , Basidiomycota/genetics , Gene Expression Regulation, Fungal , Genes, Fungal , Genes, Mating Type, Fungal , Schizophyllum/genetics , Sequence Homology, Nucleic Acid , Amino Acid Sequence , Base Composition , Cloning, Molecular , Codon , Introns , Molecular Sequence Data , Schizophyllum/growth & development
SELECTION OF CITATIONS
SEARCH DETAIL
...